ORGANISATION/COMPANYWeizmann Institute of Science
RESEARCH FIELDBiological sciences › Biology
RESEARCHER PROFILEFirst Stage Researcher (R1)
APPLICATION DEADLINE01/10/2020 00:00 - Europe/Athens
LOCATIONIsrael › Rehovot
TYPE OF CONTRACTTemporary
HOURS PER WEEK40
OFFER STARTING DATE01/04/2020
Triple negative breast cancer (TNBC) is a highly aggressive disease that affects young women and currently has no effective treatment. The goal of our studies is to identify new therapeutic strategies for this particular subtype of breast cancer.
Synthetic lethality is a powerful approach to selectively eliminate vulnerable cancer cells, and thus can be exploited for cancer therapy. Many studies including our own indicate that synthetic lethality screens could be a promising approach to identify novel drug targets for TNBC. A postdoctoral position is available to establish a genome-wide synthetic lethal screen to identify potent combination therapies for TNBC subtypes.
REQUIRED EDUCATION LEVELBiological sciences: PhD or equivalent
We search for a highly motivated candidate with a background in cell signaling and biochemistry. Individuals with experience with animal models are preferred.
Date of PhD approval should be less than 5 years
EURAXESS offer ID: 498028
The responsibility for the jobs published on this website, including the job description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.
Please contact email@example.com if you wish to download all jobs in XML.